The Economy on Psychiatric Drugs

The Economy on Psychiatric Drugs
Adderall XR capsules are displayed on Feb. 24, 2023, in a file photo. AP Photo/Jenny Kane
Jeffrey A. Tucker
Updated:
0:00
Commentary
This past week, the Atlantic ran an utterly fascinating interview with a person who went on psychiatric drugs as a young student, kept and maintained the habit into adulthood, experienced a professional crisis, and finally left the habit completely as a new father. His name is Cooper Davis, and now he runs a nonprofit consultancy for people who are attempting to kick the habit.
Jeffrey A. Tucker
Jeffrey A. Tucker
Author
Jeffrey A. Tucker is the founder and president of the Brownstone Institute and the author of many thousands of articles in the scholarly and popular press, as well as 10 books in five languages, most recently “Liberty or Lockdown.” He is also the editor of “The Best of Ludwig von Mises.” He writes a daily column on economics for The Epoch Times and speaks widely on the topics of economics, technology, social philosophy, and culture. He can be reached at [email protected]